BioCentury
ARTICLE | Financial News

Cellectar amends follow-on

November 22, 2016 12:40 AM UTC

Cellectar amended its follow-on and added Aegis Capital as an underwriter; Ladenburg Thalmann remains an underwriter. The company plans to sell up to $10 million in common stock, plus five-year warran...

BCIQ Company Profiles

Cellectar Biosciences Inc.